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 
Abstract— Deep brain stimulation is an established surgical 
treatment for several neurological and movement disorders, 
such as Parkinson’s disease, in which electrostimulation is 
applied to targeted deep nuclei in the basal ganglia through 
implanted electrode leads. Recent technological improvements 
in the field have focused on the theoretical advantage of current 
steering and adaptive (closed-loop) deep brain stimulation. 
Current steering between several active electrodes would allow 
for improved accuracy when targeting the desired brain 
structures. This has the additional benefit of avoiding undesired 
stimulation of neural tracts that are related to side effects, e.g. 
internal capsule fibres of passage in subthalamic nucleus deep 
brain stimulation. Closed-loop deep brain stimulation is based 
on the premise of continuous recording of a proxy for 
pathological neural activity (such as beta-band power of 
measured local field potentials in patients with Parkinson’s 
disease) and accordingly adapting the used stimulus parameters. 
In this study, we investigate the suitability of an existing high-
resolution neurorecording probe for high-precision 
neurostimulation. If a subset of the probe’s recording electrodes 
can be used for stimulation, then the probe would be a suitable 
candidate for closed-loop deep brain stimulation. A finite-
element model is used to calculate the electric potential, induced 
by current injection through the high-resolution probe, for 
different sets of active electrodes. Volumes of activated tissue are 
calculated and a comparison is made between the high-
resolution probe and a conventional stimulation lead. We 
investigate the capability of the probe to shift the volume of 
activated tissue by steering currents to different sets of active 
electrodes. Finally, safety limits for the injected current are used 
to determine the size of the volume in which neurons can be 
activated with the relatively small electrodes patches on the high-
resolution probe.     
I. INTRODUCTION 
Deep brain stimulation is a surgical treatment for 
movement and neurological disorders, such as Parkinson’s 
disease [1] or essential tremor [2], in which a current is applied 
through electrodes that are placed in deep brain nuclei, such as 
the subthalamic nucleus (STN), the globus pallidus (GP) or the 
ventral intermediate nucleus (Vim) of the thalamus. In 
practice, suboptimal placement of the electrode leads or high 
current injections can result in stimulation-related side-effects, 
such as facial contractions, ocular deviations, dysarthria, mood 
and cognitive changes, due to current spread outside the target 
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region [3]. Consequently, non-uniform volumes of tissue 
activated (VTA), would allow targeting with high precision a 
nucleus or fibre pathway. This improved stimulation accuracy 
would result in a reduction of undesired stimulation-induced 
side effects and a decrease of the total injected charge. 
Furthermore, studies have shown a topographical organization 
of the neuronal projections to and from the STN [4, 5, 6, 7, 8], 
even indicating a somatotopic mapping of  motor functions in 
humans. It has been theorized that access to this topology of 
the subthalamic nucleus, through high-resolution targeting of 
the VTA, could result in better treatment of movement 
disorders with deep brain stimulation [9]. In conclusion, 
localized micro-stimulation by a high-resolution array could 
be beneficial, both to elucidate the therapeutic mechanism of 
deep brain stimulation by simultaneously stimulating and 
recording the evoked response, and as a novel DBS technology 
for treatment [9]. The high number of active electrodes could 
be controlled, through a closed-loop implementation of 
(adaptive) deep brain stimulation [10]. To this end, a proxy for 
neurological pathology can be used, such as beta-band power 
in the spectrum of the local field potentials measured by the 
recording electrodes. 
The goal of this study is to explore the potential of an 
existing high-resolution recording probe [11], for closed-loop 
deep brain stimulation and high-precision targeting of neuron 
subpopulations. Due to the small electrode areas, relatively 
high charge densities are necessary to induce a reasonable size 
of the VTA. Consequently, safety limits as reported in 
literature for micro-electrodes are used, to determine the upper 
bound of current that can be injected [12, 13, 14].  
II. METHODS 
An existing high-resolution recording probe [11] and a 
conventional deep brain stimulation lead (Mo. 3389, 
Medtronic Inc., Minneapolis, MN, USA) are modeled in 
Sim4life (Sim4life, ZMT Zurich MedTech AG), see Fig. 1. 
The recording probe consists of 960 rectangular pixels, each 
containing a single (12 𝜇𝑚)2 electrode patch. A finite-
element method is used to solve the Ohmic electroquasi-static 
equation:    
 ∇ ⋅ 𝜎∇𝜙 = 0. (1)
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Figure 1. Potential distributions induced by application of 1 V to a single 
electrode. Bright colours indicate a higher electrical potential. 
The figures do not share the same scale. (a) High resolution 
recording probe (4.45 μA injection). (b) Conventional lead for 
deep brain stimulation (Medtronic 3889) (0.846 mA injection). 
Here, 𝜙 is the electric potential and 𝜎 is a uniform conductivity 
(𝜎 = 0.1 
𝑆
𝑚
). First, simulations are performed with a single 
active electrode, by imposing 1 𝑉  on the electrode-patch and 
0 𝑉 at the outer boundary of the simulation domain (Dirichlet 
conditions). Vanishing flux conditions are applied at the 
floating electrode patches and insulated parts of the DBS-leads 
(Neumann-conditions).  Second, the injected current is 
calculated by integrating the current density in Sim4life over a 
surface, enclosing the active electrode. It was observed that the 
electrode impedance did only depend on the transversal 
electrode location (close or far from the lead’s edge), and not 
on the longitudinal position. The potential distribution 𝜙 for 
the general case of current injection through multiple active 
electrodes is then determined through rescaling, translation 
and linear superposition of the potential distributions.    
 To determine the volume of tissue activated, the approach 
used in Martens et al. [15] is followed, i.e. the VTA is 
calculated by thresholding the activating function 𝐴𝐹 to 
20 𝑚𝑉. The activating function was first introduced by Rattay 
[16, 17, 18], and is given by: 
  𝐴𝐹𝑧(𝑥, 𝑦, 𝑧) = 𝜙(𝑥, 𝑦, 𝑧 − Δ𝑧) − 2𝜙(𝑥, 𝑦, 𝑧) + 𝜙(𝑥, 𝑦, Δ𝑧) 
Here, Δ𝑧 = 0.5 𝑚𝑚 is the distance between two nodes of 
Ranvier, under the assumption that intermodal myelin has 
infinite impedance. This is a typical intermodal distance, for 
basal ganglia fibres with a diameter of 5 𝜇𝑚 [15, 19]. The 
neuronal fibres are considered to be aligned with the neuronal 
probe (i.e. oriented in the z-direction), cfr. [15]. 𝐴𝐹𝑧 appears in 
the right-hand side of the neuronal cable equation, such that 
positive and negative 𝐴𝐹𝑧 will favor depolarization  and 
hyperpolarization, respectively. A good initial approximation 
of the VTA is obtained through thresholding the 𝐴𝐹𝑧 to 
20 𝑚𝑉, which is the activation threshold corresponding with 
a pulse duration 𝜏𝑝 of 60 𝜇𝑠 [20]. 
Due to the small surface areas of the electrode patches on 
the high-resolution recording probe, it is important to 
determine the maximal charge that can safely be injected. The 
Shannon-equation describes the limit between damaging and 
non-damaging electrical stimulation [12] and is based on a 
data-set obtained by McCreery [21, 22]:  
 𝐼𝜏𝑝 = √10
𝑘𝐴 (2)
Here, 𝐴 is the electrode surface area, expressed in 𝑐𝑚2 and 
𝑄 =  𝐼𝜏𝑝  is the injected charge in 𝜇𝐶. The adjustable 
parameter 𝑘 is typically chosen between 1.5 and 2. E.g., 𝑘 =
1.5 is used in the original publication by Shannon [12], while 
𝑘 = 1.75 can be used to obtain the maximum injected charge 
density of 30 𝜇𝐶/𝑐𝑚2 for which the first deep brain stimulator 
(Medtronic Activa Tremor Control System) was approved in 
the US [23, 24]. This maximum charge density 𝐷 =
30 𝜇𝐶/𝑐𝑚2 corresponds to the electrode area 𝐴 = 0.06 𝑐𝑚2 
of the Medtronic-lead (corresponding to 𝐼 = 30 𝑚𝐴 for 𝜏𝑝 =
60 𝜇𝑠 in this study). 
Equation (2) is meant as a near-field safety limit, that is 
dependent on both the charge density and the injected charge. 
The Shannon-equation attributes this codependence of the 
safety limit on injected charge and charge density to the 
inhomogeneous distribution of the current density over the 
electrode patch [12]. Higher current densities are found at the 
electrode edges, resulting in a linear proportionality between 
the safe current and the edge length of the patch (note the 
square root in (2)). However, a modeling study performed by 
McIntyre and Grill demonstrates that the potential distribution 
induced by conical micro-electrodes with suface areas 
between 100 𝜇𝑚2 and 1000 𝜇𝑚2 can be approximated by a 
point source for distances larger than 50 𝜇𝑚 [25]. This result 
indicates that the near-field assumption in the Shannon-
equation is not valid for micro-electrodes. Instead, a safety 
limit on the injected charge (𝑄 < 4 𝑛𝐶/𝑝ℎ) emerges from 
experimental data on micro-electrode stimulation [14, 26, 27].  
Both the Shannon-equation for macro-electrodes and the 
4 𝑛𝐶/𝑝ℎ limit should be used with care, because damaging 
levels will also depend on factors not explicitly taken into 
account, such as the stimulation duration, pulse duration, duty 
cycle, pulse rate, electrode shape and material [3, 12, 14]. 
Furthermore, also the type of neuronal tissue is important, due 
to differences in the packing density, fibre diameter and 
neuronal metabolism [3, 14]. However, in this explorative 
study, that aims to investigate the potential of a high-recording 
probe for micro-stimulation, we will use the mentioned limits 
as guidelines for the current that can be safely injected by the 
electrodes.  
III. RESULTS AND DISCUSSION 
Current injections well below the safety limits are able to 
induce a volume of activated tissue with a diameter of several 
millimeters, with the conventional DBS-lead (see Fig. 2). In 
Fig. 2, it is demonstrated how the VTA can be shifted along 
the conventional lead, by steering the current to different 
electrodes. The precision with which the VTA can be placed, 
is determined by the separation between the electrodes. In the 
case of the Medtronic 3389 lead, millimeter accuracy in the 
localization of the VTA can be achieved. In contrast, targeting 
of the VTA with the high-resolution probe can be done with 
significantly higher accuracy, as is shown in Fig. 3. 
Computational results indicate that micrometer precision 
targeting of stimulation regions can be achieved with the 
existing high-resolution recording probe. In Fig. 3, it is shown 




Figure 2. Volume of tissue activated by a conventional (Medtronic) DBS lead. Insulated parts are in green and electrodes are in blue. 
The blue volume is the region in which the activating function exceeds 20 𝑚𝑉 (VTA). (Left) -2.5 mA injection by 
electrode 0, (middle) -1.25 mA injection by electrode 0 and electrode 1, (right) -2.5 mA injection by electrode 1. 
 
between the different active patches. Injecting current at the 
safety limit (𝐼 = −66.6 𝜇𝐴 or 4 𝑛𝐶/𝑝ℎ) through 150 
subsequent electrode patches (corresponding to 1.5 𝑚𝑚 in 
the z-direction) results in neuronal activation (𝐴𝐹 ≥ 20 𝑚𝑉) 
in a region of several millimeter (results not shown). This 
result is similar to the results in Fig. 2 (left or right), where 
𝐼 = −2.5 𝑚𝐴 is injected through a single electrode with an 
axial length of 1.5 𝑚𝑚 on the Medtronic lead. However, in 
the case of the Medtronic 3389 lead, this volume of activated 
tissue is achieved with charge injection well below the safety 
limit of 30 𝜇𝐶/𝑐𝑚2. Consequentially, the application of the 
high-resolution probe  would focus on the benefits of more 
local and precise neurostimulation, potentially accessing the 
topological organization of the subthalamic nucleus. 
Furthermore, the relatively small size of the probe would 
reduce the risk of surgical-related complications.
 
Figure 3.  Volume of tissue activated by a high-resolution recording probe. Insulated parts are in green and electrode patches are in 
blue. The blue volume is the region in which the activating function exceeds 20 mV (VTA). (Left) −0.5 𝜇𝐴 injection by 
electrode-patch 442, (middle) −0.25 𝜇𝐴 injection by electrode patch 442 and patch 445, (right) −0.5 𝜇𝐴 injection by 




Computational modeling was used to investigate the 
stimulating capability of an existing high-resolution probe. 
The neurorecording probe is able to target the VTA with 
micrometer precision. Furthermore, a reasonable volume of 
activated neurons can be achieved by imposing 𝐼 = −66.6 𝜇𝐴 
on 150 subsequent electrode patches. However, this current 𝐼  
corresponds to a proposed safety limit for charge injection 
with micro-electrodes. It is not well understood, how 
simultaneous injection of charge through multiple 
neighbouring electrodes would impact the safe charge limit. 
Furthermore, other factors such as the pulse rate and duty 
cycle, could influence safety limits as well. Consequentially, 
application of the high-resolution probe would focus on the 
benefits of local and precise neurostimulation, instead of large 
volumes of activated tissue. Furthermore, the small size of the 
probe is likely to result in a reduction of surgical-related side-
effects, such as hemorrhage. The authors intend to use this 
work as a basis for future research, which will include more 
detailed computational simulations (neuronal membrane 
dynamics, tissue inhomogeneity and anisotropy, …) and in 
vivo experiments to establish safety and efficacy of the probe 
for therapeutic applications. Furthermore, we will investigate 
several options to maximize the probe’s performance and 
flexibility, such as increasing the electrode size (i.e. to use the 
whole shank width), investigating new electrode materials and 
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